Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: J Allergy Clin Immunol. 2011 Nov 21;129(3):664–670. doi: 10.1016/j.jaci.2011.10.013

Table 4.

GEE estimates of selected asthma outcomes over time for Symptom Free Days, Hospitalizations and ED visits

Parameter Estimate p
Symptom-Free Days
 Time 2.20 0.03
 Baseline Symptom Free Days 0.57 0.001
 Breathmobile only −0.59 0.50
 FACI only −0.85 0.33
  Breathmobile+FACI −0.36 0.69
 Breathmobile only* time2 1.92 0.17
 FACI only* time2 2.14 0.11
  Breathmobile+FACI* time2 3.43 0.01
 Breathmobile only* time3 0.12 0.93
 FACI only* time3 −0.01 0.99
  Breathmobile+FACI* time3 0.35 0.81
Hospitalizations
 Time 0.35 0.04
 Baseline Hospitalizations 1.82 0.001
 Breathmobile only 1.07 0.83
 FACI only 0.51 0.08
  Breathmobile+FACI 1.23 0.57
 Breathmobile only* time2 0.77 0.68
 FACI only* time2 0.98 0.98
  Breathmobile+FACI* time2 0.23 0.08
 Breathmobile only* time3 1.81 0.40
 FACI only* time3 1.59 0.51
  Breathmobile+FACI* time3 0.45 0.39
ED visits
 Time 0.49 0.001
 Baseline ED visits 1.29 0.001
 Breathmobile only 0.59 0.001
 FACI only 0.87 0.29
  Breathmobile+FACI 0.91 0.51
 Breathmobile only* time2 0.99 0.99
 FACI only* time2 1.69 0.01
  Breathmobile+FACI* time2 1.19 0.45
 Breathmobile only* time3 1.24 0.35
 FACI only* time3 1.00 0.99
  Breathmobile+FACI* time3 0.35 0.81

Parameter estimates for ED visits and hospitalizations are based on Incidence Rate Ratio (IRR). The estimates for symptom-free days are based on unstandardized regression coefficient (b).